ArticlePloS one2025
Silent spread of mcr-9 in ESBL-producing Enterobacteriaceae clinical isolates, Jimma, Ethiopia.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMobile colistin resistance (MCR) genes, have been increasingly identified worldwide, but their presence and characteristics in Africa remain poorly understood. Herein, we characterized a silent mcr-9 gene carried in Enterobacteriaceae from Ethiopia.
methodsIn a study investigating genomic epidemiology of ESBL-producing Gram-negative bacilli from clinical samples in 2016, eleven isolates were found to encode mcr-9 genes. Whole genome sequencing, combining Illumina and MinION Nanopore technologies were performed for in-depth investigation of the genome and understand the genetic contexts of mcr-9 and its associated plasmids.
resultThe mcr-9 genes were detected in Enterobacter cloacae (n = 8), Escherichia coli (n = 1), Klebsiella pneumoniae (n = 1), and K. michiganensis (n = 1). They were isolated from urine (54.5%, 6/11), wound secretions (27.3%, 3/11), and fecal samples (n = 18.2%, 2/11). In addition to mcr-9, all isolates encoded blaCTX-M-15, and aac (6')-Ib-cr among several other resistance genes. These isolates were susceptible to colistin (MIC ≤ 0.5 mg/L). The E. cloacae strains belong to three different sequence types (ST): ST114 (n = 3), ST184 (n = 3), ST254 (n = 1), and Enterobacter mori ST2197 (n = 1)), whereas the E. coli and the K. pneumoniae strains belonged to ST410 and ST337. IncHI2 and IncHI2A plasmid replicons were present in all isolates. Although the genetic content of plasmids carrying the mcr-9 genes varied, the genetic contexts surrounding all mcr genes within ±10kb region were largely consistent, mostly flanked by composite transposons such as IS26, and IS903B.
conclusionA silent mcr-9 gene was detected among ESBL-producing Enterobacteriaceae isolates. The IncHI2 plasmids encoding the mcr-9 had 25% genetic content dissimilarity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.